Source: Hematology, Transfusion and Cell Therapy. Unidades: FM, FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, QUIMIOTERAPIA, CUSTOS DE MEDICAMENTOS
ABNT
CHIESA, Sitânia et al. Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia. Hematology, Transfusion and Cell Therapy, v. 46, n. suppl. 6, p. S136-S143, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2024.02.028. Acesso em: 13 fev. 2026.APA
Chiesa, S., Rego, E. M., Teich, V., Madeira, M. I. A., Figueiredo-Pontes, L. L., Traina, F., & Marani, L. O. (2024). Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia. Hematology, Transfusion and Cell Therapy, 46( suppl. 6), S136-S143. doi:10.1016/j.htct.2024.02.028NLM
Chiesa S, Rego EM, Teich V, Madeira MIA, Figueiredo-Pontes LL, Traina F, Marani LO. Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( suppl. 6): S136-S143.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.htct.2024.02.028Vancouver
Chiesa S, Rego EM, Teich V, Madeira MIA, Figueiredo-Pontes LL, Traina F, Marani LO. Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( suppl. 6): S136-S143.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.htct.2024.02.028
